coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    West Hove PCN, Brighton and Hove (LAD) · Health Inequalities Profile

    PCN U14062 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    40,473

    Registered population

    61.5% aged 18–64

    18.7%

    Aged 65+

    ICB 21.9% · England 17.9%

    13.3%

    Ethnic minority (non-White)

    3.9% Asian · England 9.6%

    13.5%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~5,466

    Core20 residents (est.)

    Resident basis; registered basis ~6,152 · see page 3

    6,063

    Hypertension register

    +8.46% in 3 yrs · England +5.60%

    434

    SMI register

    9.4% of Brighton and Hove (LAD)'s

    989

    COPD register

    Reviews +5.05% in 3 yrs

    Forecast to 2030

    7,033

    Hypertension patients, 2030

    +970 on today

    66.8%

    QRISK ≥20% on statins, 2030

    +1.82pp over 3 yrs

    4.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    65.0%
    Cardiovascular treatment thresholds trail England.

    Under-80s blood pressure control is 65.0% (England 67.8%) and QRISK ≥ 20% lipid therapy is 63.0% (England 63.6%), which may reflect titration lags.

    42.2 pp
    Wide inter-practice immunisation and access variation.

    QOF vaccination achievement spans 42.2 pp from 38.9% at Mile Oak Medical Centre to 81.0% at Portslade Health Centre, alongside a 35.1 pp phone-access.

    +10.7 pp
    Physical health checks in SMI outpace benchmarks.

    Blood pressure recording on the mental health register rose +10.7 pp over 2023 to 2025 (England +4.4 pp), reaching 86.5% against 83.4% nationally.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Aged 65+ at 18.7% and children at 19.7% exceed borough rates in West Hove

    West Hove PCN serves 40,473 registered patients. Children aged 0-17 comprise 19.7% (7,988 patients), above Brighton and Hove (LAD) (15.0%) and NHS Sussex Integrated Care Board (17.7%), and in line with England (19.6%). Patients aged 65+ make up 18.7% (7,586 patients), above the LAD (14.0%), below the ICB (21.9%) and above England (17.9%). Usual residents are 86.7% White (LAD 85.4%, ICB 91.0%, England 81.1%), leaving a 13.3% ethnic minority share. Practice list sums (45,197) and registered 0-17 sums (8,767) exceed PCN totals.

    Age profile

    0–1719.7%
    18–6461.5%
    65+18.7%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White86.7%
    Mixed4.3%
    Asian3.9%
    Other3.7%
    Black1.4%

    Older people · falls rows are Brighton and Hove (LAD) local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Brighton and Hove LA)2,7022,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)78.6%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)57.8%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Brighton and Hove LA)1,4859819552024/25
    Falls deaths, all ages, per 100,000 (Brighton and Hove LA)19.914.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    West Hove PCN has 13.5% Core20 patients, distributed unevenly by concentration and volume

    West Hove PCN has an average IMD decile of 5.5 and 13.5% of registered patients in the Core20 cohort, below England (21.0%) and Brighton and Hove (LAD) (17.6%) but above NHS Sussex Integrated Care Board (9.2%). Weighted practice share is 13.61% versus the 13.49% PCN figure (a 0.12 percentage point difference). Mile Oak Medical Centre has the highest Core20 concentration at 15.28% (1,333 estimated patients), while Wish Park Surgery holds the largest volume at 1,503 estimated patients (12.98% share). Deprivation outreach requires balancing high-concentration targeting with high-volume clinical case management.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Mile Oak15.3% · 1,333 patients
    Links Road14.6% · 687 patients
    Hove13.8% · 1,236 patients
    Wish Park13.0% · 1,503 patients
    Portslade12.4% · 1,393 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    434

    SMI register

    1.04% recorded prevalence

    271

    Learning disability register

    0.65% recorded prevalence

    30

    Care homes, 823 beds

    In the PCN catchment

    8.2%

    Provide unpaid care

    Brighton and Hove (LAD), Census 2021

    Learning disability prevalence is 0.7% (271 patients; LAD 0.6%, ICB 0.6%, England 0.6%) and severe mental illness is 1.0% (434 patients; LAD 1.4%, ICB 1.1%, England 1.0%). The catchment includes 30 care homes with 823 beds, though resident registrations are unconfirmed.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 1.0% (434 patients; England 1.0%). Across the PCN, 86.5% of SMI patients received a blood pressure check (England 83.4%). Practice recording rates vary: Hove Medical Centre achieved 79.0% and Links Road Surgery reached 73.0%.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,063

    Hypertension register

    +8.46%

    Register growth, 3 yrs

    Brighton and Hove (LAD) +7.27% · England +5.60%

    +1.17pp

    BP control, under 80

    ≤140/90 · +4.69pp aged 80+

    +970

    More patients by 2030

    Forecast 7,033 (17.06%)

    Hypertension case-finding and control

    The PCN hypertension register includes 6,063 patients, giving a recorded prevalence of 14.5% against 10.5% in Brighton and Hove (LAD), 16.3% in NHS Sussex Integrated Care Board and 15.2% in England. The register grew +8.5% over 2023 to 2025 (England +5.6%). While 89.8% of patients have a recent blood pressure check (England 90.0%), blood pressure control in patients aged under 80 is 65.0%, below England (67.8%) and the ICB (66.8%), with three-year improvement at +1.8% trailing England (+3.2%). Overall blood pressure treated to target stands at 67.6% (England 70.3%). Current snapshot observation periods were not captured. With blood pressure control in under-80s lagging national benchmarks despite register growth, treatment titration and recall remain key priorities.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy uptake is 63.0%, trailing England (63.6%) though above Brighton and Hove (LAD) (58.9%). Three-year uptake rose +3.0% over 2023 to 2025 (England +6.2%). In CKD, lipid therapy reaches 70.9% (England 70.3%). Reviewing high-risk primary prevention patients lacking lipid therapy could help close the gap against England.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202664,381£2.60£2.42£1.86£167,391
    Cardiovascular (all), 202585,732£2.91£3.32£3.33£249,480

    In 2026, the PCN prescribed 64,381 lipid-regulating drug items at £2.60 per item, above Brighton and Hove (LAD) (£2.47), NHS Sussex Integrated Care Board (£2.42) and England (£1.86). Across these items, the PCN spent £47,642 more than at England's unit cost and £11,589 more than at the ICB's unit cost. Prescribing choices can be reviewed against ICB formulary guidance.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +10.91%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.49%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.4% (989 patients), exceeding England (1.9%), Brighton and Hove (LAD) (1.6%) and NHS Sussex Integrated Care Board (2.0%), after growing +17.8% over 2023 to 2025 (England +2.6%). Current COPD reviews stand at 76.2% (England 76.4%). Asthma prevalence is 7.3% (2,891 patients; England 6.6%). While 12-month asthma reviews rose +10.9% over 2023 to 2025 to 66.2% (England +4.4%, reaching 65.7%), an estimated 976 patients (about 980) lack a recorded annual review. Prioritising structured asthma reviews would address this unreviewed cohort.

    Cancer register and children's immunisation

    Cancer prevalence is 3.6% (1,522 patients; England 3.8%), rising +16.0% over 2023 to 2025 (England +9.0%). In Q1 2025/26, age-5 MMR dose 1 coverage was 96.9% (England 91.7%), while dose 2 was 91.7% (England 82.8%), reflecting a 5.2 pp dose difference. At 24 months, dose 1 coverage was 88.5% (England 88.3%). Pre-school recall could help reduce the dose drop-off before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months90.5%

    England 91.0%

    6-in-1 complete primary course at 24 months92.0%

    England 92.2%

    MMR dose 1 at 24 months88.5%

    England 88.3%

    MMR dose 2 at age 591.7%

    England 82.8%

    4-in-1 pre-school booster at age 589.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In 2022 across NHS Sussex ICB, 58.5% of staged cancers (4,799 of 8,209) were diagnosed at stage 1 or 2 (England 55.3%), 16.5 pp below the 75.0% national ambition by 2028 (requiring about 1,360 additional early-stage diagnoses annually). Known staging was 64.3% (8,209 of 12,766 registered cancers; England 67.0%). In West Hove PCN, cervical screening coverage in women aged 25 to 49 is 71.2% (England 66.8%), falling 3.1% over 2023 to 2025 (England -1.0%). Across captured practices, coverage is 67.2% at Links Road Surgery, 67.7% at Portslade Health Centre, and 68.3% at Hove Medical Centre. ICB staging describes the wider system rather than PCN performance; declining local screening may delay.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), University Hospitals Sussex NHS Foundation Trust met the 62-day cancer referral to treatment standard for 65.2% of pathways (414 of 635), below East Sussex Healthcare NHS Trust (67.0%), Surrey and Sussex Healthcare NHS Trust (70.0%), NHS Surrey and Sussex Integrated Care Board (71.5%), England (71.2%), and the 85.0% standard. The trust achieved 74.0% on the 28-day faster diagnosis standard (ICB 79.3%; 75.0% standard). In diagnostics, 6-week waits were 5.6% for MRI, 8.6% for CT, and 57.0% for audiology assessments (England 41.5%). These acute trust and diagnostic waiting times describe provider activity rather than PCN performance.

    Pathways within standard (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0184.2077.7479.2979.32
    31-day treatment (96%)76.7998.1996.2090.4592.50
    62-day referral to treatment (85%)65.2067.0469.9771.5171.16
    Diagnostic waits over 6 weeks (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareEngland
    MRI5.626.4827.5321.40
    CT8.570.4818.499.92
    Echocardiography0.3921.9443.7828.48
    Colonoscopy39.350.7415.1130.83
    Gastroscopy20.020.3121.0629.02
    All 15 DM01 tests12.955.2728.5023.14
    Community services activityBrighton and Hove residentsSurrey and Sussex ICB
    Care contacts23,615309,615
    Referrals5,59066,930
    Patients with a contact7,35085,660

    Community services (residents of Brighton and Hove), Jun 2026 (provisional). In Jun 2026 (provisional), adults aged 65 and over accounted for 60.7% of all community service contacts among Brighton and Hove residents (14,325 of 23,615 contacts). Provider- and PCN-level community activity was not captured. These resident contacts describe borough-level service demand rather than PCN activity, indicating that older adults represent the majority of local community contacts.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Immunisation and overall QOF achievement vary across member practices

    In 2025/26, overall QOF achievement ranged from 83.9% at Links Road Surgery to 96.0% at Portslade Health Centre. In vaccination and immunisation, achievement spanned 42.2 pp, ranging from 38.9% at Mile Oak Medical Centre to 81.0% at Portslade Health Centre. Delivery variation suggests network-wide review of immunisation call and recall processes.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Portslade9212.450.3%65.1%83.4%
    Hove12313.854.4%71.3%82.4%
    Links Road Surgery8414.682.4%78.8%81.9%
    Mile Oak10715.347.3%64.9%76.0%
    Wish Park Surgery11313.056.9%69.9%72.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBrighton and Hove (LAD)AssetPCNBrighton and Hove (LAD)
    Care homes (catchment)30 (823 beds)n/aSchools (catchment)39n/a
    Children's centres514Places of worship25113
    Libraries313Homelessness support (VCS)0no data
    Primary schools (LA maintained)735Primary academies57
    Special schoolsn/a2

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Pharmacist CVD titration and lipid recall

    Under-80s hypertension BP control is 65.0% (England 67.8%, ICB 66.8%) and QRISK ≥ 20% lipid therapy is 63.0% (England 63.6%); patient counts are not captured. For discussion, the PCN could run pharmacist-led titration and statin-initiation clinics for patients already on the hypertension and high-QRISK registers, prioritising high-Core20 practices. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured annual asthma review catch-up

    Although asthma reviews rose +10.9% to 66.2% (England 65.7%, LAD 60.1%) across 2,891 registered patients (7.3% prevalence), an estimated 976 (about 980) patients lack a 12-month review. For discussion, practices could run a standardised asthma review recall with extended or after-school slots and combined inhaler checks. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Practice-targeted immunisation and access review

    QOF vaccination achievement spans 42.2 pp (38.9% at Mile Oak Medical Centre to 81.0% at Portslade Health Centre; England 55.2%), and age-5 MMR drops 5.2 pp from dose 1 (96.9%) to dose 2 (91.7%; England 82.8%). Moderate effort to run.

    Evidence base: the share of patients in the most deprived quintile is the Core20 targeting measure used to weight inequalities funding, outreach and prevention capacity, and the gradient every clinical indicator should be read against.

    Policy anchor: Core20PLUS5 (Core20 = the most deprived 20% by IMD); 10 Year Health Plan, with widening inequalities the equity test of reform.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Practice list reconciliation (p2)Registered population · Aged 0-17Neighbourhood health framework · Medium Term Planning Framework 2026PCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Target SMI physical checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension titration and recall review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Pharmacist CVD titration and lipid recall (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Structured annual asthma review catch-up (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Practice-targeted immunisation and access review (p12)Core20 cohort (IMD quintile 1) · MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5Core20PLUS5 · 10YHP equity test · 10YHP sickness to prevention · 95% targetPCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15